Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Experience of patisiran optimization building healthcare team
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: HPS-038
- By: MARTINEZ SESMERO, Jose Manuel ()
- Co-author(s): Ms Ana Andrea Garcia Sacristan, Pharmacy (Hospital Clinico San Carlos, Madrid, Spain)
Ms. Cristina Gonzalez Perez, pharmacy
Mr. Jose Manuel Martinez Sesmero, pharmacy
Ms Lucia Galan Davila, neurology
Transthyretin (TTR) amyloidosis is a rare disease caused by mutations in the TTR gene. These mutations alter the normal function of TTR protein, creating slowly progressive condition characterized by the buildup of abnormal deposits of amyloid in body's organs and tissues.
Patisiran is a TTR specific small interfering RNA (siRNA).. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019